The role of computer-assisted radiographer reporting in lung cancer screening programmes.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 18 01 2022
accepted: 13 04 2022
revised: 11 03 2022
pubmed: 15 5 2022
medline: 17 9 2022
entrez: 14 5 2022
Statut: ppublish

Résumé

Successful lung cancer screening delivery requires sensitive, timely reporting of low-dose computed tomography (LDCT) scans, placing a demand on radiology resources. Trained non-radiologist readers and computer-assisted detection (CADe) software may offer strategies to optimise the use of radiology resources without loss of sensitivity. This report examines the accuracy of trained reporting radiographers using CADe support to report LDCT scans performed as part of the Lung Screen Uptake Trial (LSUT). In this observational cohort study, two radiographers independently read all LDCT performed within LSUT and reported on the presence of clinically significant nodules and common incidental findings (IFs), including recommendations for management. Reports were compared against a 'reference standard' (RS) derived from nodules identified by study radiologists without CADe, plus consensus radiologist review of any additional nodules identified by the radiographers. A total of 716 scans were included, 158 of which had one or more clinically significant pulmonary nodules as per our RS. Radiographer sensitivity against the RS was 68-73.7%, with specificity of 92.1-92.7%. Sensitivity for detection of proven cancers diagnosed from the baseline scan was 83.3-100%. The spectrum of IFs exceeded what could reasonably be covered in radiographer training. Our findings highlight the complexity of LDCT reporting requirements, including the limitations of CADe and the breadth of IFs. We are unable to recommend CADe-supported radiographers as a sole reader of LDCT scans, but propose potential avenues for further research including initial triage of abnormal LDCT or reporting of follow-up surveillance scans. • Successful roll-out of mass screening programmes for lung cancer depends on timely, accurate CT scan reporting, placing a demand on existing radiology resources. • This observational cohort study examines the accuracy of trained radiographers using computer-assisted detection (CADe) software to report lung cancer screening CT scans, as a potential means of supporting reporting workflows in LCS programmes. • CADe-supported radiographers were less sensitive than radiologists at identifying clinically significant pulmonary nodules, but had a low false-positive rate and good sensitivity for detection of confirmed cancers.

Identifiants

pubmed: 35567604
doi: 10.1007/s00330-022-08824-1
pii: 10.1007/s00330-022-08824-1
pmc: PMC9474336
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

6891-6899

Subventions

Organisme : Cancer Research UK
ID : 28706
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T02481X/1
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
pubmed: 33538338
Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409
doi: 10.1056/NEJMoa1102873
de Koning HJ, van der Aalst CM, de Jong PA et al (2020) reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382:503–513
doi: 10.1056/NEJMoa1911793
Pastorino U, Silva M, Sestini S et al (2019) Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol 30(7):1162–1169
doi: 10.1093/annonc/mdz117
NHS England (2019) Targeted screening for lung cancer with low radiation dose computed tomography: standard protocol prepared for the Targeted Lung Health Checks Programme. NHS England, London. Available via: https://www.england.nhs.uk/wp-content/uploads/2019/02/targeted-lung-health-checks-standard-protocol-v1.pdf
Beyer F, Zierott L, Fallenberg EM et al (2007) Comparison of sensitivity and reading time for the use of computer-aided detection (CAD) of pulmonary nodules at MDCT as concurrent or second reader. Eur Radiol 17(11):2941–2947
doi: 10.1007/s00330-007-0667-1
Wang Y, van Klaveren RJ, de Bock GH et al (2012) No benefit for consensus double reading at baseline screening for lung cancer with the use of semiautomated volumetry software. Radiology 262(1):320–326
doi: 10.1148/radiol.11102289
Zhao Y, de Bock GH, Vliegenthart R et al (2012) Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume. Eur Radiol 22:2076–2084
doi: 10.1007/s00330-012-2437-y
Al Mohammad B, Brennan PC, Mello-Thoms C (2017) A review of lung cancer screening and the role of computer-aided detection. Clin Radiol 72(6):433–442
doi: 10.1016/j.crad.2017.01.002
Morgan L, Choi H, Reid M, Khawaja A, Mazzone PJ (2017) Frequency of incidental findings and subsequent evaluation in low-dose computed tomographic scans for lung cancer screening. Ann Am Thorac Soc 14(9):1450–1456
doi: 10.1513/AnnalsATS.201612-1023OC
Snaith B, Hardy M, Lewis EF (2015) Radiographer reporting in the UK: a longitudinal analysis. Radiography 21(2):119–123
doi: 10.1016/j.radi.2014.10.001
Woznitza N, Piper K, Rowe S, Bhowmik A (2018) Immediate reporting of chest X-rays referred from general practice by reporting radiographers: a single centre feasibility study. Clin Radiol 73(5):507.e1–507.e8
doi: 10.1016/j.crad.2017.11.016
Woznitza N, Piper K, Burke S, Bothamley G (2018) Chest X-ray Interpretation by radiographers is not inferior to radiologists: a multireader, multicase comparison using JAFROC (Jack-knife Alternative Free-response Receiver Operating Characteristics) Analysis. Acad Radiol 25(12):1556–1563
doi: 10.1016/j.acra.2018.03.026
Nair A, Screaton NJ, Holemans JA et al (2018) The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial. Eur Radiol 28(1):226–234
doi: 10.1007/s00330-017-4903-z
Nair A, Gartland N, Barton B et al (2016) Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial. Br J Radiol. https://doi.org/10.1259/bjr.20160301
Ritchie AJ, Sanghera C, Jacobs C et al (2016) Computer vision tool and technician as first reader of lung cancer screening CT scans. J Thorac Oncol 11(5):709–717
doi: 10.1016/j.jtho.2016.01.021
Ruparel M, Quaife SL, Dickson JL et al (2020) Lung Screen Uptake Trial: results from a single lung cancer screening round. Thorax 75:908–912
doi: 10.1136/thoraxjnl-2020-214703
Quaife SL, Ruparel M, Beeken RJ et al (2016) The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and “hard-to-reach” patients. BMC Cancer. https://doi.org/10.1186/s12885-016-2316-z
Callister MEJ, Baldwin DR, Akram AR et al (2015) BTS guidelines for the investigation and management of pulmonary nodules. Thorax 70(Suppl 2)
Vlahos I, Stefanidis K, Sheard S, Nair A, Sayer C, Moser J (2018) Lung cancer screening: nodule identification and characterization. Transl Lung Cancer Res 7(3):288–303
doi: 10.21037/tlcr.2018.05.02
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174
doi: 10.2307/2529310
Holland P, Spence H, Clubley A, Brooks C, Baldwin D, Pointon K (2020) Reporting radiographers and their role in thoracic CT service improvement: managing the pulmonary nodule. BJR Open. https://doi.org/10.1259/bjro.20190018
Walter JE, Heuvelmans MA, de Jong PA et al (2016) Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 17(7):907–916
doi: 10.1016/S1470-2045(16)30069-9
Gendarme S, Goussault H, Assi J, Taleb C, Chouaïd C, Landre T (2021) Impact on all-cause and cardiovascular mortality rates of coronary artery calcifications detected during organized, low-dose, computed-tomography screening for lung cancer: systematic literature review and meta-analysis. Cancers. https://doi.org/10.3390/cancers13071553
Bartlett EC, Belsey J, Derbyshire J et al (2021) Implications of incidental findings from lung screening for primary care: data from a UK pilot. NPJ Prim Care Respir Med. https://doi.org/10.1038/s41533-021-00246-8
Horst C, Dickson JL, Tisi S et al (2020) Delivering low-dose CT screening for lung cancer: a pragmatic approach. Thorax 75(10):831–832
doi: 10.1136/thoraxjnl-2020-215131
Mazzone P, Silvestri G, Patel S et al (2018) Screening for lung cancer: Chest guideline and expert panel report. Chest 153(4):954–985

Auteurs

Helen Hall (H)

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, 5 University Street, London, WC1E 6JF, UK.

Mamta Ruparel (M)

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, 5 University Street, London, WC1E 6JF, UK.

Samantha L Quaife (SL)

Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Jennifer L Dickson (JL)

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, 5 University Street, London, WC1E 6JF, UK.

Carolyn Horst (C)

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, 5 University Street, London, WC1E 6JF, UK.

Sophie Tisi (S)

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, 5 University Street, London, WC1E 6JF, UK.

James Batty (J)

Department of Radiology, University College London Hospital, London, UK.

Nicholas Woznitza (N)

Department of Radiology, Homerton University Hospital, London, UK.

Asia Ahmed (A)

Department of Radiology, University College London Hospital, London, UK.

Stephen Burke (S)

Department of Radiology, Homerton University Hospital, London, UK.

Penny Shaw (P)

Department of Radiology, University College London Hospital, London, UK.

May Jan Soo (MJ)

Department of Radiology, Homerton University Hospital, London, UK.

Magali Taylor (M)

Department of Radiology, University College London Hospital, London, UK.

Neal Navani (N)

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, 5 University Street, London, WC1E 6JF, UK.
Department of Thoracic Medicine, University College London Hospital, London, UK.

Angshu Bhowmik (A)

Department of Thoracic Medicine, Homerton University Hospital, London, UK.

David R Baldwin (DR)

Respiratory Medicine Unit, David Evans Research Centre, Nottingham University Hospitals, Nottingham, UK.

Stephen W Duffy (SW)

Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Anand Devaraj (A)

Department of Radiology, Royal Brompton Hospital, London, UK.
National Heart and Lung Institute, Imperial College London, London, UK.

Arjun Nair (A)

Department of Radiology, University College London Hospital, London, UK.

Sam M Janes (SM)

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, 5 University Street, London, WC1E 6JF, UK. s.janes@ucl.ac.uk.
Department of Thoracic Medicine, University College London Hospital, London, UK. s.janes@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH